search
Back to results

Exercise Following Autologous Peripheral Blood Stem Cell Transplantation

Primary Purpose

Hematological Disease

Status
Unknown status
Phase
Phase 3
Locations
Germany
Study Type
Interventional
Intervention
Supervised exercise
Sponsored by
Charite University, Berlin, Germany
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Hematological Disease focused on measuring High-dose chemotherapy, Hematological neoplasties, Fatigue, Cancer, Exercise, Sport, Hematologic neoplastic disorders

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 18-70
  • Hematological disease
  • Treatment with high-dose chemotherapy followed by autologous stem cell transplantation
  • Understanding of written German

Exclusion Criteria:

  • Cardiorespiratory, metabolical, osteoarticular or immunological diseases which can be aggravated by exercise
  • Pathological stress-ECG at admission

Sites / Locations

  • Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30Recruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Supervised exercise

Control group

Arm Description

The patients will not carry out a structured exercise program.

Outcomes

Primary Outcome Measures

VO2max

Secondary Outcome Measures

Mood
Duration of aplasia
Complications during hospitalization
Need for transfusion of platelets and red blood cells

Full Information

First Posted
April 17, 2009
Last Updated
December 21, 2009
Sponsor
Charite University, Berlin, Germany
search

1. Study Identification

Unique Protocol Identification Number
NCT00883961
Brief Title
Exercise Following Autologous Peripheral Blood Stem Cell Transplantation
Study Type
Interventional

2. Study Status

Record Verification Date
December 2009
Overall Recruitment Status
Unknown status
Study Start Date
December 2009 (undefined)
Primary Completion Date
April 2011 (Anticipated)
Study Completion Date
September 2011 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
Charite University, Berlin, Germany

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The study evaluates the effects of a supervised exercise program on the physical performance, the mood and the complications of therapy in patients undergoing a high-dose chemotherapy followed by an autologous peripheral blood stem cell transplantation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hematological Disease
Keywords
High-dose chemotherapy, Hematological neoplasties, Fatigue, Cancer, Exercise, Sport, Hematologic neoplastic disorders

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Supervised exercise
Arm Type
Experimental
Arm Title
Control group
Arm Type
No Intervention
Arm Description
The patients will not carry out a structured exercise program.
Intervention Type
Other
Intervention Name(s)
Supervised exercise
Intervention Description
The patients will carry out a daily endurance exercise program consisting of walking on a treadmill for 30 minutes at an intensity of about 80% of the maximum heart rate under supervision from study personnel.
Primary Outcome Measure Information:
Title
VO2max
Time Frame
At recruitment and after 3 weeks
Secondary Outcome Measure Information:
Title
Mood
Time Frame
At recruitment and after 3 weeks
Title
Duration of aplasia
Time Frame
3 weeks
Title
Complications during hospitalization
Time Frame
3 weeks
Title
Need for transfusion of platelets and red blood cells
Time Frame
3 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 18-70 Hematological disease Treatment with high-dose chemotherapy followed by autologous stem cell transplantation Understanding of written German Exclusion Criteria: Cardiorespiratory, metabolical, osteoarticular or immunological diseases which can be aggravated by exercise Pathological stress-ECG at admission
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Fernando Dimeo, MD
Phone
+493084452098
Email
fernando.dimeo@charite.de
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fernando Dimeo, MD
Organizational Affiliation
Charite University, Berlin, Germany
Official's Role
Principal Investigator
Facility Information:
Facility Name
Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30
City
Berlin
ZIP/Postal Code
12200
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fernando Dimeo, MD
First Name & Middle Initial & Last Name & Degree
Fernando Dimeo, MD

12. IPD Sharing Statement

Learn more about this trial

Exercise Following Autologous Peripheral Blood Stem Cell Transplantation

We'll reach out to this number within 24 hrs